Darryl Maher

2.1k total citations · 1 hit paper
23 papers, 1.3k citations indexed

About

Darryl Maher is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Darryl Maher has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Darryl Maher's work include Neutropenia and Cancer Infections (5 papers), Respiratory viral infections research (3 papers) and Platelet Disorders and Treatments (3 papers). Darryl Maher is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Respiratory viral infections research (3 papers) and Platelet Disorders and Treatments (3 papers). Darryl Maher collaborates with scholars based in Australia, Belgium and United Kingdom. Darryl Maher's co-authors include Jonathan Cebon, John A.M. Gall, Graham J. Lieschke, D Metcalf, Edouard G. Stanley, Vincent Sinickas, Ashley R. Dunn, D Grail, G. S. Hodgson and Qiyuan Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Critical Care Medicine.

In The Last Decade

Darryl Maher

22 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

1994 678 citations Edouard G. Stanley, Graham J. Lieschke et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Darryl Maher Australia	13	720	324	276	205	186	23	1.3k
J B Baker United States	8	668 0.9×	328 1.0×	281 1.0×	279 1.4×	183 1.0×	8	1.4k
Osamu Saiki Japan	21	788 1.1×	233 0.7×	113 0.4×	219 1.1×	95 0.5×	52	1.4k
Barbara Biedermann Switzerland	17	591 0.8×	184 0.6×	235 0.9×	250 1.2×	409 2.2×	28	1.5k
Tsuyoshi Takahashi Japan	19	439 0.6×	252 0.8×	121 0.4×	144 0.7×	164 0.9×	72	1.1k
Christof Iking‐Konert Germany	23	811 1.1×	148 0.5×	333 1.2×	282 1.4×	176 0.9×	67	1.8k
T Miyawaki Japan	16	489 0.7×	136 0.4×	157 0.6×	177 0.9×	181 1.0×	20	945
Dimitri Flieger Germany	21	1.2k 1.7×	624 1.9×	291 1.1×	457 2.2×	112 0.6×	51	2.1k
Laurence Bouchet‐Delbos France	21	781 1.1×	337 1.0×	206 0.7×	277 1.4×	48 0.3×	37	1.5k
Cécile Taflin France	8	1.7k 2.4×	427 1.3×	152 0.6×	170 0.8×	112 0.6×	9	2.1k
Guido Wolff-Vorbeck Germany	15	836 1.2×	136 0.4×	219 0.8×	122 0.6×	88 0.5×	40	1.3k

Countries citing papers authored by Darryl Maher

Since Specialization

Citations

This map shows the geographic impact of Darryl Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darryl Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darryl Maher more than expected).

Fields of papers citing papers by Darryl Maher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darryl Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darryl Maher. The network helps show where Darryl Maher may publish in the future.

Co-authorship network of co-authors of Darryl Maher

This figure shows the co-authorship network connecting the top 25 collaborators of Darryl Maher. A scholar is included among the top collaborators of Darryl Maher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darryl Maher. Darryl Maher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Young, Megan K, et al.. (2017). Rubella antibodies in Australian immunoglobulin products. Human Vaccines & Immunotherapeutics. 13(8). 1952–1955. 4 indexed citations

Rockman, Steven, Sue Lowther, Sarina Camuglia, et al.. (2017). Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection. EBioMedicine. 19. 119–127. 25 indexed citations

Empson, Marianne, Mimi L.K. Tang, Constance H. Katelaris, et al.. (2012). Efficacy, Safety and Pharmacokinetics of a Novel Subcutaneous Immunoglobulin, Evogam®, in Primary Immunodeficiency. Journal of Clinical Immunology. 32(5). 897–906. 6 indexed citations

Rockman, Steven, Darryl Maher, & Deborah Middleton. (2011). The use of hyperimmune serum for severe influenza infections*. Critical Care Medicine. 40(3). 973–975. 11 indexed citations

Favaloro, Emmanuel J., J. V. Lloyd, John Rowell, et al.. (2007). Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.. PubMed. 97(6). 922–30. 29 indexed citations

Che, Yan, et al.. (2006). Impact of manufacturing improvements on clinical safety of albumin: Australian pharmacovigilance data for 1988–2005. Critical Care and Resuscitation. 8(4). 334–338. 9 indexed citations

Presneill, Jeffrey, Paul Waring, Judith E. Layton, et al.. (2000). Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: Relation to disease severity, multiple organ dysfunction, and mortality. Critical Care Medicine. 28(7). 2344–2354. 38 indexed citations

Basser, Russell L., L. Bik To, John P. Collins, et al.. (1999). Multicycle High-Dose Chemotherapy and Filgrastim-Mobilized Peripheral-Blood Progenitor Cells in Women With High-Risk Stage II or III Breast Cancer: Five-Year Follow-Up. Journal of Clinical Oncology. 17(1). 82–82. 21 indexed citations

Clarke, Kerrie, Russell L. Basser, Craig Underhill, et al.. (1999). KRN8602 (MX2-Hydrochloride): An Active New Agent for the Treatment of Recurrent High-Grade Glioma. Journal of Clinical Oncology. 17(8). 2579–2579. 14 indexed citations

10.

Morgan, Denis J., John S. Hill, Kerrie Clarke, et al.. (1998). Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant disease. Cancer Chemotherapy and Pharmacology. 41(5). 423–426. 1 indexed citations

11.

Morgan, Denis J., John S. Hill, Stanley S. Stylli, et al.. (1997). Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant disease. Cancer Chemotherapy and Pharmacology. 40(3). 202–208. 1 indexed citations

12.

Basser, R., L. Bik To, C. Glenn Begley, et al.. (1995). Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells.. PubMed. 1(7). 715–21. 31 indexed citations

13.

Waring, Paul, Jeffrey Presneill, Darryl Maher, et al.. (1995). Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia. Clinical & Experimental Immunology. 102(3). 501–506. 24 indexed citations

14.

Chen, Qiyuan, Vincent C. Daniel, Darryl Maher, & Peter Hersey. (1994). Production of IL‐10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma. International Journal of Cancer. 56(5). 755–760. 205 indexed citations

15.

Chen, Qiyuan, Melanie Smith, Tam Nguyen, Darryl Maher, & Peter Hersey. (1994). T cell recognition of melanoma antigens in association with HLA-A1 on allogeneic melanoma cells. Cancer Immunology Immunotherapy. 38(6). 385–393. 7 indexed citations

16.

Cebon, Jonathan, Judith E. Layton, Darryl Maher, & George Morstyn. (1994). Endogenous haemopoietic growth factors in neutropenia and infection. British Journal of Haematology. 86(2). 265–274. 129 indexed citations

17.

Stanley, Edouard G., Graham J. Lieschke, D Grail, et al.. (1994). Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.. Proceedings of the National Academy of Sciences. 91(12). 5592–5596. 678 indexed citations breakdown →

18.

Maher, Darryl, Ian D. Davis, Andy Boyd, & George Morstyn. (1991). Human interleukin-4: An immunomodulator with potential therapeutic applications. PubMed. 3(1). 43–56. 24 indexed citations

19.

Maher, Darryl, Beverley L. Pike, & Andy Boyd. (1990). The Response of Human B Cells to Interleukin 4 is Determined by their Stage of Activation and Differentiation. Scandinavian Journal of Immunology. 32(6). 631–640. 13 indexed citations

20.

Firkin, Frank & Darryl Maher. (1988). Cytotoxic immunosuppressive drug treatment strategy in pure red cell aplasia. European Journal Of Haematology. 41(3). 212–217. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact